Arcutis’ Zoryve Cream for AD Hits Pharmacy Shelves
Arcutis Biotherapeutics’ is launching of roflumilast cream 0.15% (Zoryve) for the treatment of mild-to-moderate atopic dermatitis (AD) in adults and children down to age 6 in the United States. In addition, Arcutis today also announced the signing of a co-promotion agreement with Kowa Pharmaceuticals America, Inc. The agreement will leverage Kowa’s primary care sales force […]